Breakthroughs

٣٫٠ (١)
علوم حياة

Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Produced and funded by Pfizer Ltd. PP-UNP-GBR-13569 / October 2025

١٥‏/١٢‏/٢٠٢٥

Part of the Story: Sherlock Holmes and The Adventure of the Silent Hiss

Despite recent scientific progress, society and particularly the media oversimplifies, or sensationalises cancer. The way that cancer is portrayed does not reflect the reality for patients today. We’ve created a new chapter, ‘The Adventure of the Silent Hiss’, to ‘The Return of Sherlock Holmes’ collection of short stories, which sees the famous detective navigate a cancer diagnosis while successfully solving another mystery. Written in collaboration with patients and narrated by voice actor and cancer survivor, Brett Harman, the new chapter aims to shift the narrative to better reflect the fact that advances in treatment and detection are helping many people with the disease live better and longer lives. Whether cancer comes at the beginning, middle or end of a person’s life, it is never the whole story and does not need to define it. This story, inspired by characters created by Sir Arthur Conan Doyle, was commissioned and funded by Pfizer Ltd. It takes artistic licence but is informed by insights from people living with cancer. It is intended for the UK general public and is not meant to replace the advice of a qualified health professional. PP-UNP-GBR-13946 / December 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

٢٥ من الدقائق
١٠‏/١٢‏/٢٠٢٥

Confronting the stigma of lung cancer

To end season 2, our expert panel discusses some of the challenges and misconceptions that need to be overcome in the fight against lung cancer and the progress being made. Our host Dr Ellie Cannon is joined by Dr Jesme Fox, Medical Director at the Roy Castle Lung Cancer Foundation, and Stefano Podesta, Oncology Commercial Lead at Pfizer UK. PP-UNP-GBR-13858 / December 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

٢٧ من الدقائق
٠٣‏/١٢‏/٢٠٢٥

Breast cancer: widely known, but often overlooked

Our expert panel discusses the progress being made in the fight against breast cancer and some of the challenges that need to be tackled to improve patient care in the future. Our host Dr Ellie Cannon is joined by Helen Dickens, Chief Support Officer at Breast Cancer Now, and Colm Doody, Oncology Medical Director at Pfizer UK. PP-UNP-GBR-13734 / November 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

٣٧ من الدقائق
٢٠‏/١١‏/٢٠٢٥

A fair shot: exploring vaccines access and equity

Dr Ellie Cannon is joined by Lord Bethell, Member of the House of Lords, and Hetal Naik, Primary Care Lead at Pfizer UK, to discuss the evolving role of vaccines in the UK’s prevention strategy and how to help improve equitable vaccine access. PP-UNP-GBR-13788 / November 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

٢٧ من الدقائق
٠٥‏/١١‏/٢٠٢٥

Uncovering heart failure

In this episode our expert panel discuss the topic of heart failure, exploring what it is, symptoms to be aware of, diagnosis, and the impact it can have on daily life. Our host Dr Ellie Cannon is joined by Anna Tomlinson, CEO at Cardiomyopathy UK, and Seema Patel, Specialty Care Medical Director at Pfizer UK. PP-UNP-GBR-13584 / October 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

٣٥ من الدقائق
٢٢‏/١٠‏/٢٠٢٥

The hidden challenges of multiple myeloma

In this episode our expert panel discuss multiple myeloma, exploring some of the challenges of the disease and progress being made to help patients in the UK. Our host Dr Ellie Cannon is joined by Dr Sophie Castell, CEO at Myeloma UK, and Colm Doody, Oncology Medical Director at Pfizer UK. PP-UNP-GBR-13445 / October 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

٣١ من الدقائق
٠٨‏/١٠‏/٢٠٢٥

Gaining independence with haemophilia

To kick off season 2, our panel explores the impact that haemophilia has on patients and their families and the scientific progress being made to enable people with haemophilia to lead more independent lives. Our host Dr Ellie Cannon is joined by Kate Burt, Chief Executive at The Haemophilia Society, and Seema Patel, Specialty Care Medical Director at Pfizer UK. PP-UNP-GBR-13338 / September 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

٣٥ من الدقائق
١٩‏/١١‏/٢٠٢٤

The vital role of immunisation for disease prevention

Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS. PP-UNP-GBR-10718 / November 2024 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

٣٤ من الدقائق

مشاهدة الكل (١٤)

Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Produced and funded by Pfizer Ltd. PP-UNP-GBR-13569 / October 2025